Author: Kelly Wiese Niemeyer

The university’s International Travel Oversight Committee recently announced an update to its international travel policy for faculty, staff, and graduate and professional students starting Aug. 1.

The Washington University Board of Trustees has four new student representatives for 2021-22. The undergraduate representatives are Tennyson Holmes and Gaby Smith; the graduate student representatives are Bryanna Brown and Kendall Burks.

Julie O’Neal, assistant professor of medicine at the School of Medicine, received a $250,000 award from the International Myeloma Society. The award will be used to develop novel immunotherapy treatments for multiple myeloma, a common blood cancer.

A research team at Washington University School of Medicine has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.

The Division of Physician-Scientists at the School of Medicine has selected four physicians for its second class of Dean’s Scholars. The program provides up to two years of financial support and mentorship to aspiring, early-career physician-scientists, along with dedicated time for conducting laboratory research.

Antibiotic sales soared during India’s first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to research led by the School of Medicine. Such overuse increases the risk for drug-resistant infections worldwide.

Philip R. O. Payne, director of the Institute for Informatics at the School of Medicine, has been elected a fellow of the International Academy of Health Sciences Informatics.

Kristen Kroll, professor of developmental biology at the School of Medicine, has received a four-year $2.1 million grant from the National Institutes of Health (NIH) for her project on human interneuron progenitor specification.

Workday, WashU’s new human resources and financial administrative system, will launch tomorrow, July 1. Here, Chancellor Andrew D. Martin shares a video message marking this important milestone and thanking the team that worked on the project.

Researchers at Washington University School of Medicine have shown in preclinical studies that a natural killer cell-based immunotherapy could be effective against solid tumors such as melanoma.